Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
Link |
1 | Borghaei, H (Borghaei, H.);...; Steins, M;...; Kohlhäufl, M;...; Brahmer, JR | Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer NEW ENGL J MED 373(17): 1627-39 (22 OCT 2015) | 6.127 | Link |
2 | Reck, M;...; Brahmer, JR | Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer NEW ENGL J MED 375(19): 1823-33 (10 NOV 2016) | 5.589 | Link |
3 | Brahmer, J;...; Eberhardt, WEE;...; Steins, M;...; Reck, M;...; Spigel, DR | Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer NEW ENGL J MED 373(2): 123-35 (9 JUL 2015) | 4.739 | Link |
4 | Gandhi, L;...; Hochmair, MJ;...; Bischoff, HG;...; Reck, M;...; Garassino, MC | Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer NEW ENGL J MED 378(22): 2078-92 (31 MAY 2018) | 3.077 | Link |
5 | Quanjer, PH;...; Baur, X;...; Stocks, J | Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations EUR RESPIR J 40(6): 1324-43 (DEC 2012) | 2.950 | Link |
6 | Rittmeyer, A;...; von Pawel, J;...; Gandara, DR | Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial LANCET 389(10066): 255-65 (21 JAN 2017) | 2.808 | Link |
7 | Canc Genome Atlas Res Network [412 Autoren, darunter aus D Pfeifer, M; Thomas, RK; David, K; Muley, T] | Comprehensive genomic characterization of squamous cell lung cancers NATURE 489(7417): 519-25 (27 SEP 2012) | 2.568 | Link |
8 | Shaw, AT;...; Thomas, M;...; Janne, PA | Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer NEW ENGL J MED 368(25): 2385-94 (20 JUN 2013) | 2.532 | Link |
9 | Richeldi, L;...; Costabel, U;...; Stowasser, S;...; Disse, B; Collard, HR | Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis NEW ENGL J MED 370(22): 2071-82 (29 MAY 2014) | 2.402 | Link |
10 | Canc Genome Atlas Res Network [371 Autoren, darunter 5 aus D] | Comprehensive molecular profiling of lung adenocarcinoma NATURE 511(7511): 543-50 (30 JUL 2014) | 2.305 | Link |